image
Amylyx Pharmaceuticals, Inc. AMLX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.76
-5.18 %
$ 326 M
Market Cap
-1.25
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 1612.94% 124.84% 119.27%
Annual Report FY 10-K 2022-12-31 7700.00% -125.74% -143.49%
Annual Report FY 10-K 2021-12-31 -56.15% -96.00% -111.99%
Annual Report FY 10-K 2020-12-31 -54.42% -202.63% -187.77%
Annual Report FY 10-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -99.59% -347.98% -404.17%
Quarterly Report Q2 8-K 2024-06-30 -1.04% -329.35% -264.52%
Quarterly Report Q1 8-K 2024-03-31 24.10% -7552.00% -5848.86%
Quarterly Report Q4 8-K 2023-12-31 395.54% 111.08% 104.34%
Quarterly Report Q3 8-K 2023-09-30 29666.09% 138.87% 134.23%
Quarterly Report Q2 8-K 2023-06-30 0.00% 140.83% 137.23%
Quarterly Report Q1 8-K 2023-03-31 0.00% 103.29% 95.71%
Quarterly Report Q4 8-K 2022-12-31 0.00% -50.66% -57.49%
Quarterly Report Q3 8-K 2022-09-30 21.05% -132.29% -138.59%
Quarterly Report Q2 8-K 2022-06-30 0.00% -146.63% -191.89%
Quarterly Report Q1 8-K 2022-03-31 0.00% -229.46% -271.57%
Quarterly Report Q4 8-K 2021-12-31 0.00% -229.89% -229.55%
Quarterly Report Q3 8-K 2021-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2021-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2021-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2020-12-31 0.00% 0.00% 0.00%